Seeing Is Believing

Currently out of the existing stock ratings of Gena Wang, 212 are a BUY (69.74%), 58 are a HOLD (19.08%), 34 are a SELL (11.18%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 64.24% that have a potential upside of 32.17% achieved within 179 days.
Gena Wang’s has documented 642 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on CYTK, Cytokinetics at 28-Jan-2026.
Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2019
$425
$110.6 (35.18%)
$325
2 days ago
(13-Feb-2026)
12/13 (92.31%)
$110.6 (35.18%)
252
Buy Since 22-Nov-2021
$510
$195.6 (62.21%)
$529
3 days ago
(12-Feb-2026)
22/24 (91.67%)
$187.72 (58.25%)
185
Hold Since 24-Feb-2023
$408
$93.6 (29.77%)
$268
16 days ago
(30-Jan-2026)
10/11 (90.91%)
$69.94 (20.69%)
39
Buy Since 12-Feb-2021
$510
$195.6 (62.21%)
$570
16 days ago
(30-Jan-2026)
22/28 (78.57%)
$171.94 (50.86%)
671
Buy Since 21-Nov-2019
$462
$147.6 (46.95%)
$529
16 days ago
(30-Jan-2026)
10/13 (76.92%)
$123.94 (36.66%)
142
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?